Abstract |
|
Authors | Ian Rechner, Finella Brito-Babapulle, Jonathan Fielden |
Journal | The hematology journal : the official journal of the European Haematology Association
(Hematol J)
Vol. 4
Issue 1
Pg. 54-6
( 2003)
ISSN: 1466-4860 [Print] England |
PMID | 12692521
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Granulocyte Colony-Stimulating Factor
- Thalidomide
- Vincristine
- Dexamethasone
- Doxorubicin
- Cyclophosphamide
- Methylprednisolone
- Hydroxyurea
|
Topics |
- Adult
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, therapeutic use)
- Capillary Leak Syndrome
(chemically induced, drug therapy, physiopathology)
- Combined Modality Therapy
- Critical Care
- Cyclophosphamide
(therapeutic use)
- Dexamethasone
(administration & dosage)
- Doxorubicin
(administration & dosage)
- Dyspnea
(etiology)
- Edema
(etiology, physiopathology)
- Fasciitis, Necrotizing
(etiology)
- Fatal Outcome
- Granulocyte Colony-Stimulating Factor
(adverse effects, therapeutic use)
- Hematopoietic Stem Cell Mobilization
(adverse effects)
- Humans
- Hydroxyurea
(administration & dosage)
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
(complications, drug therapy, therapy)
- Male
- Methylprednisolone
(therapeutic use)
- Middle Aged
- Models, Biological
- Multiple Myeloma
(complications, drug therapy, therapy)
- Peripheral Blood Stem Cell Transplantation
- Thalidomide
(therapeutic use)
- Vasculitis, Leukocytoclastic, Cutaneous
(chemically induced)
- Vincristine
(administration & dosage)
|